Abstract
Background: Pre-eclampsia (P-EC) is a pregnancy-specific disorder, characterised by placental insufficiency and endothelial dysfunction. It is a significant cause of maternal and fetal morbidity. Women with a history of P-EC have heightened risks of future cardiovascular and thromboembolic disease. In addition, pre- clamptic patients have elevated levels of clotting and angiogenic factors; however it is unclear whether these changes persist postpartum. Aims: The aim of this study was to investigate the relationship between haemostatic as well as angiogenic and anti-angiogenic factors in women with a past-history of P-EC, including vascular endothelial growth factor (VEGF), placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng), in combination with tissue factor (TF) and TF pathway inhibitor (TFPI), also whether these factors were altered postpartum in women with a history of P-EC. Methods: The study followed a case-control design. Blood samples were obtained at 6-12 months postpartum from 21 primiparous women after a pregnancy affected by P-EC, and 21 women with a previously unaffected pregnancy. Plasma concentrations of each of the factors were determined using enzyme-linked immunosorbent assay. Results: Significant differences were not observed in levels of VEGF (p=0.068), PlGF (p=0.333), sFlt-1 (p=0.910), sEng (p=0.612), TF (p=0.260) or TFPI (p=0.786) between women with and without a history of pre-eclampsia. Additionally, no significant difference was found in the TF: TFPI ratio between case and control groups (p=0.734). Conclusion: This study does not support the hypothesis that levels of VEGF, PlGF, sFlt-1, sEng, TF or TFPI are altered in women with a history of P-EC compared to controls. However, we observed a weak positive association between all parameters measured. While we acknowledge that this is a pilot study and that the sample sizes is relatively small, our results suggest that circulating haemostatic, angiogenic and anti-angiogenic factors are not significantly altered in women with a past-history of P-EC.
Highlights
Pre-eclampsia (P-EC) is a syndrome of pregnancy characterised by new onset, persistent hypertension and proteinuria after 20 weeks gestation [1]
Significant differences were not observed in levels of vascular endothelial growth factor (VEGF) (p=0.068), placental growth factor (PlGF) (p=0.333), soluble fms-like tyrosine kinase-1 (sFlt-1) (p=0.910), soluble endoglin (sEng) (p=0.612), tissue factor (TF) (p=0.260) or TF pathway inhibitor (TFPI) (p=0.786) between women with and without a history of pre-eclampsia
This study does not support the hypothesis that levels of VEGF, PlGF, sFlt-1, sEng, TF or TFPI are altered in women with a history of P-EC compared to controls
Summary
Pre-eclampsia (P-EC) is a syndrome of pregnancy characterised by new onset, persistent hypertension and proteinuria after 20 weeks gestation [1]. It is known that normal pregnancy is associated with increased levels of a number of clotting and angiogenic factors, factors VII, VIII, X, von Willebrand factor and fibrinogen These changes serve mainly as a protective mechanism to reduce haemorrhaging during childbirth; the resulting hypercoagulable states may subsequently leads to an increased risk of venous thromboembolic disease during pregnancy [4]. Studies have shown that in pregnancies complicated by P-EC the risks of thromboembolic disease are further heightened during gestation This is likely due to additional alterations in clotting and angiogenic factors, as well as a higher prevalence of various thrombophilias amongst pre-eclamptic women [5]. Pre-eclampsia (P-EC) is a pregnancy-specific disorder, characterised by placental insufficiency and endothelial dysfunction It is a significant cause of maternal and fetal morbidity. Pre-eclamptic patients have elevated levels of clotting and angiogenic factors; it is unclear whether these changes persist postpartum
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
